AAAAAA
Results:
1-7
|
Results: 7
The role of X-chromosome inactivation in female predisposition to autoimmunity (vol 2, pg 399, 2000)
Authors:
Chitnis, S
Monteiro, J
Glass, D
Apatoff, B
Salmon, J
Concannon, P
Gregersen, PK
Citation: S. Chitnis et al., The role of X-chromosome inactivation in female predisposition to autoimmunity (vol 2, pg 399, 2000), ARTHRITIS R, 3(3), 2001, pp. 399-399
Authors:
Harrington, KJ
Mohammadtaghi, S
Uster, PS
Glass, D
Peters, AM
Vile, RG
Stewart, JSW
Citation: Kj. Harrington et al., Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes, CLIN CANC R, 7(2), 2001, pp. 243-254
Authors:
Cunliffe, WJ
Glass, D
Goode, K
Stables, GI
Boorman, GC
Citation: Wj. Cunliffe et al., A double-blind investigation of the potential systemic absorption of isotretinoin, when combined with chemical sunscreens, following topical application to patients with widespread acne of the face and trunk, ACT DER-VEN, 81(1), 2001, pp. 14-17
Authors:
Chitnis, S
Monteiro, J
Glass, D
Apatoff, B
Salmon, J
Concannon, P
Gregersen, PK
Citation: S. Chitnis et al., The role of X-chromosome inactivation in female predisposition to autoimmunity, ARTHRITIS R, 2(5), 2000, pp. 399-406
Authors:
Jucquois, I
Nihoyannopoulos, P
D'Hondt, AM
Roelants, V
Robert, A
Melin, JA
Glass, D
Vanoverschelde, JLJ
Citation: I. Jucquois et al., Comparison of myocardial contrast echocardiography with NC100100 and Tc-99m sestamibi SPECT for detection of resting myocardial perfusion abnormalities in patients with previous myocardial infarction, HEART, 83(5), 2000, pp. 518-524
Authors:
Paul, DB
Clay, CL
Harber, B
Croop, H
Glass, D
Scotti, S
Citation: Db. Paul et al., Extreme environment structures, PROG ASTRON, 188, 2000, pp. 145-199
Authors:
Glass, D
Boorman, GC
Stables, GI
Cunliffe, WJ
Goode, K
Citation: D. Glass et al., A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris, DERMATOLOGY, 199(3), 1999, pp. 242-247
Risultati:
1-7
|